YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance

YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance

Malignant melanoma, with its increasing incidence and high potential to form metastases, is one of the most aggressive types of skin malignancies responsible for a significant number of deaths worldwide. However, melanoma also demonstrates a high potential for induction of a specific adaptive anti-t...

Full description

Bibliographic Details
Main Authors: Dominika Kwiatkowska, Ewelina Mazur, Adam Reich
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
malignant melanoma
immunotherapy
treatment resistance
YY1
PD1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.856963/full

Similar Items

Similar Items